Management of 2.8cm Ostium Secundum ASD with Deficient Aortic and Posterior Rims in a 54-Year-Old Female
This patient requires closure of the ASD, but the deficient aortic margin and thin posterior rim make surgical repair the definitive treatment rather than transcatheter device closure. 1
Initial Hemodynamic Assessment Required
Before proceeding with any intervention, you must establish:
- Pulmonary artery systolic pressure (must be <50% of systemic pressure for Class I indication, or <2/3 systemic for any consideration of closure) 1
- Pulmonary vascular resistance (must be <1/3 systemic resistance for Class I indication, or <2/3 systemic for any consideration) 1
- Qp:Qs ratio (should be ≥1.5:1 to confirm hemodynamically significant shunt) 1, 2
- Right ventricular and right atrial size (enlargement confirms hemodynamic significance) 1, 2
- Presence or absence of cyanosis at rest and during exercise using pulse oximetry 1
Cardiac catheterization is reasonable to assess these parameters definitively, particularly given her age and potential for pulmonary hypertension 1
Why Surgical Closure is Indicated Over Transcatheter Approach
The deficient aortic margin and thin posterior rim are anatomic contraindications to percutaneous device closure. 3, 4
- Deficient posterior rim is a major predictor of device closure failure, with high rates of device embolization and misalignment 3
- Absent or deficient aortic rim creates instability for device placement and increases erosion risk 3
- At 2.8cm (28mm), the defect size itself is within the range for device closure, but the rim deficiencies override this consideration 1, 3
- Transcatheter closure requires adequate rims for device stability—your patient lacks this critical anatomic requirement 3, 4
Surgical Management Strategy
Surgical patch closure via sternotomy is the definitive treatment. 1, 2
The procedure should include:
- Patch closure of the secundum ASD using either pericardial or synthetic patch material 1
- Intraoperative assessment of pulmonary venous connections using transesophageal echocardiography or direct visualization 1
- Evaluation for concomitant tricuspid valve pathology that may require repair 1
- Surgery must be performed by a surgeon with expertise in adult congenital heart disease 2, 5
At age 54, surgical outcomes remain excellent with equivalent long-term survival to younger patients, though complication rates (pneumothorax, heart failure, pneumonia) are slightly higher 5, 6
Absolute Contraindications to Closure (Must Rule Out)
Do not proceed with closure if any of the following are present: 1, 2
- PA systolic pressure >2/3 systemic pressure 1
- Pulmonary vascular resistance >2/3 systemic resistance 1
- Net right-to-left shunt (Eisenmenger physiology) 1, 2
- Severe irreversible pulmonary arterial hypertension with no left-to-right shunt 2, 5
This is fatal if missed—always exclude severe PAH before proceeding. 2
Post-Operative Management and Surveillance
Following surgical repair, monitor for:
- Atrial arrhythmias (atrial fibrillation/flutter), which require anticoagulation and rhythm control 2, 7
- Residual shunt via transthoracic echocardiography at 1 month, 3-6 months, and 1 year 5, 7
- Right ventricular size and function normalization on serial echocardiography 5, 7
- Paradoxical embolic events if any residual shunt persists 7
Critical Pitfalls to Avoid
- Do not attempt transcatheter closure in the presence of deficient aortic and posterior rims—this leads to device embolization, erosion, and procedural failure 3, 4
- Do not assume the defect is benign because the patient may be asymptomatic—acquired conditions in older adults increase left-to-right shunting over time, making previously compensated ASDs hemodynamically significant 2
- Do not proceed without hemodynamic assessment—unrecognized severe PAH makes closure fatal 2, 5
- Do not underestimate arrhythmia risk—older patients have higher rates of postoperative atrial fibrillation requiring long-term management 5, 7